1. Rader DJ. Chapter 407: Disorders of Lipoprotein Metabolism. In: Loscalzo J, Kasper DL, Longo DL, Fauci AS, Hauser SL, Jameson JL, ed. Harrison’s Principles of Internal Medicine. 21st ed. McGraw Hill; 2022:3135-3150.
2. Brown MS, Goldstein JL. A Receptor-Mediated Pathway for Cholesterol Homeostasis. Science. 1986;232(4746):34–47. https://doi.org/10.1126/science3513311.
3. Motazacker MM, Pirruccello J, Huijgen R, et al. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia. Eur Heart J. 2012;33:1360–6. https://doi.org/10.1093/eurheartj/ehs010.
4. Ison HE, Clarke SL, Knowles JW. Familial Hypercholesterolemia. 2014 Jan 2 [Updated 2022 Jul 7]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK174884/. Accessed 20 Feb 2024
5. Wiegman A, Gidding SS, Watts GF, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36:2425–37. https://doi.org/10.1093/eurheartj/ehv157.